1-2 of 2
Judit Joergensen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Sirpa Leppa, MD, Judit Joergensen, Anne Tierens, Ingunn Østlie, Unn Merete Fagerli, Peter de Nully Brown, MD, Thomas S Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Bjorkholm, Oystein Fluge, Sirkku Jyrkkio, Elisabeth Ralfkiaer, Signe Spetalen, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood
Blood (2016) 128 (22): 1854.
https://doi.org/10.1182/blood.V128.22.1854.1854
Published: 2016
Journal Articles

Preliminary Clinical Experience on the Efficacy and Feasibility of a New Combination Regimen Consisting of Pixantrone, Etoposide, and Bendamustine with or without the Addition of Rituximab in Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphomas

Francesco d'Amore, Judit Joergensen, Ida Blok Sillesen, Erik Segel, Hans Bentzen, Michael Thorsgaard, Elisa Jacobsen Pulczynski, Bjarne Bach Pedersen, Dorte Gillström, Michael Clausen, Peter Kamper, Trine Silkjaer, Lars C. Gormsen, Sirpa Leppä, Helle Toldbod
Journal: Blood
Blood (2014) 124 (21): 5435.
https://doi.org/10.1182/blood.V124.21.5435.5435
Published: 2014